» Articles » PMID: 20600754

The Effect of Acorus Gramineus on the Bioavailabilities and Brain Concentrations of Ginsenosides Rg1, Re and Rb1 After Oral Administration of Kai-Xin-San Preparations in Rats

Overview
Date 2010 Jul 6
PMID 20600754
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aim Of The Study: To investigate the effect of Acorus gramineus (AG), a supposed 'delivering servant' according to traditional Chinese medicine principles governing multi-herb formula preparation and formulation, on facilitating the uptake of ginsenosides Rg1, Re and Rb1 to the brain after oral administration of Kai-Xin-San (KXS) preparations.

Materials And Methods: Ginseng extracts or KXS with or without AG were administered to rats for pharmacokinetic study and mice for behaviour tests at a dose of 3 g ginseng per kg. The concentrations of ginsenosides in plasma and brain were determined by an LC-MS/MS method, whilst the effects of preparations on spatial learning were evaluated using the Morris water maze test.

Results: KXS in the presence of AG tended to significantly reverse the learning impairment induced by scopolamine. The presence of AG in the KXS formula led to increases in the initial absorption rate and extent of Rg1 and Re in terms of Cmax1 and AUC(0-3h) compared to KXS without AG. Although KXS were found to increase the bioavailabilities and brain concentrations of ginsenosides relative to ginseng extract, the brain-to-plasma AUC(0-12h) ratios appeared not to be affected.

Conclusions: The results suggested that the presence of AG in the KXS formula promoted the initial absorption of ginsenosides Rg1 and Re in the gastrointestinal tract, but unlikely affected the brain-to-plasma AUC ratios.

Citing Articles

Constituents, pharmacological activities, pharmacokinetic studies, clinical applications, and safety profile on the classical prescription Kaixinsan.

Chen L, Jiang L, Shi X, Yang J, Wang R, Li W Front Pharmacol. 2024; 15:1338024.

PMID: 38362144 PMC: 10867185. DOI: 10.3389/fphar.2024.1338024.


Methods on improvements of the poor oral bioavailability of ginsenosides: Pre-processing, structural modification, drug combination, and micro- or nano- delivery system.

Hu Q, Hong H, Zhang Z, Feng H, Luo T, Li J J Ginseng Res. 2023; 47(6):694-705.

PMID: 38107396 PMC: 10721471. DOI: 10.1016/j.jgr.2023.07.005.


Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations.

Zhou Z, An R, You L, Liang K, Wang X Medicine (Baltimore). 2023; 102(35):e34891.

PMID: 37657053 PMC: 10476818. DOI: 10.1097/MD.0000000000034891.


Ginsenoside and Its Therapeutic Potential for Cognitive Impairment.

Feng H, Xue M, Deng H, Cheng S, Hu Y, Zhou C Biomolecules. 2022; 12(9).

PMID: 36139149 PMC: 9496100. DOI: 10.3390/biom12091310.


Recent advances and effective strategies in the discovery and applications of natural products.

Xie J, Zhang A, Sun H, Yan G, Wang X RSC Adv. 2022; 8(2):812-824.

PMID: 35538992 PMC: 9077099. DOI: 10.1039/c7ra09475b.